RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Graybug Vision Stock

Graybug Vision ROE 2025

Graybug Vision ROE

-0.99

Ticker

GRAY

ISIN

US38942Q1031

WKN

A2QDGM

In 2025, Graybug Vision's return on equity (ROE) was -0.99, a 0% increase from the 0 ROE in the previous year.

Graybug Vision Aktienanalyse

What does Graybug Vision do?

Graybug Vision Inc is a promising biotechnology company specializing in the development of innovative therapies for eye diseases, with a focus on long-acting implants and injections to reduce the need for frequent surgeries or injections. The company collaborates with leading experts and research institutions in the field of ophthalmology to develop and improve its products, which target various eye diseases such as age-related macular degeneration (AMD), glaucoma, and diabetic retinopathy. One of their most promising products is GB-102, a long-acting injectable formulation of Aflibercept for the treatment of wet AMD. GB-102 has the potential to significantly reduce the number of injections required to alleviate symptoms, improving patients' quality of life and making the treatment more effective and cost-efficient. Graybug Vision also focuses on clinical diagnostics, developing innovative technologies and test procedures for early detection of eye diseases. By working closely with patients and doctors, they aim to enable early diagnoses and better treatment options. With their business model centered on bringing innovative technologies and products to market, Graybug Vision aims to enhance the lives of people with eye diseases. They collaborate with academic research and other companies to accelerate the development and clinical testing process. Through continuous research and development, the company seeks to strengthen its position in the field of ophthalmological therapies and offer high-quality, effective products at competitive prices. In summary, Graybug Vision Inc is a promising biotechnology company specializing in the development and commercialization of innovative therapies and diagnostic tests for eye diseases. With an experienced team of scientists and executives, the company demonstrates unparalleled determination and innovative capacity to push the boundaries of ophthalmological medicine. With its innovative and effective products, smart business model, and strong research base, Graybug Vision Inc. is well positioned to achieve a leading position in the field of ophthalmic medicine. Graybug Vision ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Graybug Vision's Return on Equity (ROE)

Graybug Vision's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Graybug Vision's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Graybug Vision's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Graybug Vision’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Graybug Vision stock

What is the ROE (Return on Equity) of Graybug Vision this year?

The ROE of Graybug Vision this year is -0.99 undefined.

How has the Return on Equity (ROE) of Graybug Vision developed compared to the previous year?

The ROE of Graybug Vision has increased by 0% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Graybug Vision?

A high ROE indicates that Graybug Vision generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Graybug Vision?

A low ROE can indicate that Graybug Vision is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Graybug Vision affect the company?

A change in ROE (Return on Equity) of Graybug Vision can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Graybug Vision?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Graybug Vision?

Some factors that can influence Graybug Vision's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Graybug Vision pay?

Over the past 12 months, Graybug Vision paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Graybug Vision is expected to pay a dividend of 0 .

What is the dividend yield of Graybug Vision?

The current dividend yield of Graybug Vision is .

When does Graybug Vision pay dividends?

Graybug Vision pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Graybug Vision?

Graybug Vision paid dividends every year for the past 0 years.

What is the dividend of Graybug Vision?

For the upcoming 12 months, dividends amounting to 0 are expected. This corresponds to a dividend yield of 0 %.

In which sector is Graybug Vision located?

Graybug Vision is assigned to the 'Health' sector.

Wann musste ich die Aktien von Graybug Vision kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Graybug Vision from 2/1/2025 amounting to 0 , you needed to have the stock in your portfolio before the ex-date on 2/1/2025.

When did Graybug Vision pay the last dividend?

The last dividend was paid out on 2/1/2025.

What was the dividend of Graybug Vision in the year 2024?

In the year 2024, Graybug Vision distributed 0 as dividends.

In which currency does Graybug Vision pay out the dividend?

The dividends of Graybug Vision are distributed in .

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Graybug Vision

Our stock analysis for Graybug Vision Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Graybug Vision Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.